TipRanks
Go Ultimate55% OFF

Kyntra Bio (KYNB) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

KYNB Analyst Ratings

Strong Buy
5Ratings
4Buy1Hold0Sell
Based on 5 analysts giving stock ratings to Kyntra Bio in the past 3 months

KYNB Stock 12 Month Forecast

MXN 723.29▲(507.81% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Kyntra Bio in the last 3 months. The average price target is MXN 723.29 with a high forecast of MXN 807.83 and a low forecast of MXN 657.54. The average price target represents a 507.81% change from the last price of MXN 119.00.
Highest Price TargetMXN 807.83Average Price TargetMXN 723.29Lowest Price TargetMXN 657.54

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:KYNB
Price TargetFollowArticle
Maxim GroupMXN 657.54buy452.55%UpsideInitiated10/13/26
H.C. WainwrightMXN 807.83buy578.85%UpsideReiterated10/05/26
Lake StreetMXN 770.26buy547.27%UpsideInitiated09/17/26
William Blair―hold―Reiterated08/31/26
OppenheimerMXN 657.54buy452.55%UpsideReiterated08/14/26
Rodman & RenshawMXN 563.60buy373.62%UpsideInitiated06/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kyntra Bio

3 Months
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate4/13 ratings generated profit
31%
Average Return
-14.53%

Copying Matthew Keller's trades and holding each position for 3 Months would result in 30.77% of your transactions generating a profit, with an average return of -14.53% per trade.

1 Year
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/13 ratings generated profit
0%
Average Return
-29.52%

Copying Matthew Keller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -29.52% per trade.

2 Years
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/13 ratings generated profit
0%
Average Return
-44.25%

Copying Matthew Keller's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -44.25% per trade.

KYNB Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for KYNB
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy34564
Buy00000
Hold12220
Sell00000
Strong Sell00000
total46784

In the current month, KYNB has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KYNB average Analyst price target in the past 3 months is 723.29.

KYNB Financial Forecast

MXN -82MXN 171.8MXN 425.5MXN 679.3MXN 933Q4 2025Q2 2026Q3 2026
HighMXN -52.99
ConsensusMXN -66.69
LowMXN -80.99

KYNB Earnings Forecast

Next quarter’s earnings estimate for KYNB is -MXN 66.69 with a range of -MXN 80.99 to -MXN 52.99. The previous quarter’s EPS was MXN 55.62. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

MXN -27.7MMXN -3.2MMXN 21.3MMXN 45.8MMXN 70.2MQ4 2025Q2 2026Q3 2026
HighMXN 63.9M
ConsensusMXN 33.2M
LowMXN 22.2M

KYNB Sales Forecast

Next quarter’s sales forecast for KYNB is MXN 33.19M with a range of MXN 22.17M to MXN 63.89M. The previous quarter’s sales results were -MXN 27.70M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

KYNB Stock Forecast FAQ

What is MX:KYNB’s average 12-month price target, according to analysts?
Based on analyst ratings, Kyntra Bio’s 12-month average price target is Mex$723.29.
What is MX:KYNB’s upside potential, based on the analysts’ average price target?
Kyntra Bio has 507.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Kyntra Bio a Buy, Sell or Hold?
Kyntra Bio has a consensus rating of Strong Buy, which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
What is Kyntra Bio’s share price target?
The average share price target for Kyntra Bio is Mex$723.29. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$807.83, and the lowest forecast is Mex$657.54. The average share price target represents a 507.81% increase from the current price of Mex$119.
What do analysts say about Kyntra Bio?
Kyntra Bio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of Kyntra Bio?
To buy shares of MX:KYNB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.